February 1, 2018 / 10:24 AM / 6 months ago

BRIEF-Novo Nordisk CEO: We Remain Committed To Grow In Biopharma Segment, Also Via Acquisitions

Feb 1 (Reuters) - Novo Nordisk A/S:

* NOVO NORDISK CEO SAYS WE REMAIN COMMITTED TO GROWTH IN THE BIOPHARMA SEGMENT, ALSO VIA ACQUISITIONS Further company coverage: (Reporting by Jacob Grønholt-Pedersen)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below